Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/inhibition-of-angiotensin-ii-induced-inositol-phosphate-production-by-9hHtw51aTC
References (37)
-
D. Mais, N. Bowling, T. True, M. Naka, T. Morinelli, Oatis Jr.R.E., N. Hamanaka, P. Halushka (1991)
1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists.Journal of Medicinal Chemistry, 34
-
C. Cazaubon, J. Gougat, F. Bousquet, P. Guiraudou, R. Gayraud, C. Lacour, A. Roccon, G. Galindo, G. Barthelemy, B. Gautret (1993)
Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.The Journal of pharmacology and experimental therapeutics, 265 2
-
P. Timmermans (1999)
Pharmacological properties of angiotensin II receptor antagonists.The Canadian journal of cardiology, 15 Suppl F
-
M. Robertson, I. Dougall, D. Harper, K. McKechnie, P. Leff, M. Roberatson, I. Dougall, D. Harper, K. McKechnie, P. Leff (1994)
Agonist-antagonist interactions at angiotensin receptors: application of a two-state receptor model.Trends in pharmacological sciences, 15 10
-
J. Duncia, D. Carini, A. Chiu, A. Johnson, W. Price, P. Wong, R. Wexler, P. Timmermans (1992)
The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonistMedicinal Research Reviews, 12
-
Y.J. Liu, N. Shankley, N. Welsh, J. Black (1992)
Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic actionBritish Journal of Pharmacology, 106
-
J. Zhang, J. Meel, M. Pfaffendorf, P. Zwieten (1994)
Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve.The Journal of pharmacology and experimental therapeutics, 269 2
-
Hiroaki Furuta, D. Guo, T. Inagami (1992)
Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor.Biochemical and biophysical research communications, 183 1
-
(1991)
1 - ( car - boxybenzyl ) imidazole - 5 - acrylic acids : potent and selective angiotensin II receptor antagonists -
(1991)
potent and selective angiotensin II receptor antagonists -
S. Mochizuki, Tomoe Sato, K. Furuta, Kenji Hase, Y. Ohkura, Chika Fukai, K. Kosakai, S. Wakabayashi, A. Tomiyama (1995)
Pharmacological Properties of KT3–671, a Novel Nonpeptide Angiotensin II Receptor AntagonistJournal of Cardiovascular Pharmacology, 25
-
M. Noda, Y. Shibouta, Y. Inada, M. Ojima, T. Wada, T. Sanada, K. Kubo, Y. Kohara, T. Naka, K. Nishikawa (1993)
Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist.Biochemical pharmacology, 46 2
-
L. Limbird (1985)
Cell surface receptors -
(1992)
Pharmacological profile of GR 117289 in vitro : A novel , potent and specific non - peptide angiotensin AT 1 receptor antagonist -
P. Morsing, G. Adler, U. Brandt-Eliasson, Linda Karp, Kristina Ohlson, L. Renberg, Per-Ove Sjöquist, T. Abrahamsson (1999)
Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.Hypertension, 33 6
-
Y. Shibouta, Y. Inada, M. Ojima, T. Wada, Masakuni Noda, T. Sanada, K. Kubo, Y. Kohara, T. Naka, K. Nishikawa (1993)
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenylThe Journal of pharmacology and experimental therapeutics, 266 1
-
H. Rang (1966)
The kinetics of action of acetylcholine antagonists in smooth muscleProceedings of the Royal Society of London. Series B. Biological Sciences, 164
-
P. Vanderheyden, F. Fierens, J. Backer, G. Vauquelin (2000)
Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.Biochemical pharmacology, 59 8
-
A. Palkowitz, Mitchell Steinberg, K. Thrasher, J. Reel, K. Hauser, Karen Zimmerman, S. Wiest, C. Whitesitt, R. Simon, W. Pfeifer (1994)
Structural evolution and pharmacology of a novel series of triacid angiotensin II receptor antagonists.Journal of medicinal chemistry, 37 26
-
Didier Courcelles, J. Leysen, P. Roevens, H. Belle (1986)
The serotonin‐S2 Receptor: A receptor‐transducer coupling model to explain insurmountable antagonist effectsDrug Development Research, 8
-
F. Fierens, P. Vanderheyden, J. Backer, G. Vauquelin (1999)
Binding of the antagonist []candesartan to angiotensin II AT1 receptor-tranfected Chinese hamster ovary cellsEuropean Journal of Pharmacology, 367
-
M. Steinberg, A. Palkowitz, K. Thrasher, J. Reel, K. Zimmerman, C. Whitesitt, Simon Lee, K. Hauser, Lifer Lynn, P. William, K. Takeuchi, S. Wiest, V. Vasudevan, K. Bermis, J. Deeter, C. Barnett, T. Wilson, W. Marshall, D. Boyd (1994)
Chiral recognition of the angiotensin II (AT1) receptor by a highly potent phenoxyproline octanoamideBioorganic & Medicinal Chemistry Letters, 4
-
Y. Shibouta, Y. Inada, M. Ojima, T. Wada, M. Noda, T. Sanada, K. Kubo, Y. Kohara, T. Naka, K. Nishikawa (1993)
Pharmacological profile of a highly potent & long-acting angiotensin II receptor antagonist, 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1 H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (±)-1-(Cyclohexyloxycarbonyloxy)-ethyl 2-Ethoxy-I-[[2'-(1H-tetrazol-5-yl) biohenyl-4-yl]methyl]-1 H-benzimidazole-7-carboxylate (TCV-116)J. Pharm. Exp. Ther., 266
-
R. Panek, G. Lu, R. Overhiser, T. Major, J. Hodges, D. Taylor (1995)
Functional studies but not receptor binding can distinguish surmountable from insurmountable AT1 antagonism.The Journal of pharmacology and experimental therapeutics, 273 2
-
P. Vanderheyden, F. Fierens, J.-P. Backer, Norbert Fraeyman, G. Vauquelin (1999)
Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO‐K1 cells expressing human angiotensin II AT1 receptorsBritish Journal of Pharmacology, 126
-
(1998)
Angiotensin antagonists. In Receptor-based drug -
M. J. Robertson (1998)
Receptor-based drug design -
F. Fierens, P. Vanderheyden, J. Backer, G. Vauquelin (1999)
Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.European journal of pharmacology, 372 2
-
L. Criscione, M. Gasparo, P. Bühlmayer, S. Whitebread, H. Ramjoue, J. Wood (1993)
Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1‐receptor subtypeBritish Journal of Pharmacology, 110
-
G. Anderson, D. Streeten, T. Dalakos (1977)
Pressor Response to 1‐Sar‐8‐Ala‐Angiotensin II (Saralasin) in Hypertensive SubjectsCirculation Research, 40
-
T. P. Kenakin (1987)
Pharmacological Analysis of Drug-Receptor Interaction -
M. Pierson, R. Freer (1992)
Analysis of the active conformation of angiotensin II: a comparison of AII and non-peptide AII antagonists.Peptide research, 5 2
-
G. Mawer (1963)
DRUG ANTAGONISM.Current medicine and drugs, 4 2
-
L. E. Limbird (1996)
A short course on theory and methods -
M. Robertson, J. Barnes, G. Drew, K. Clark, F. Marshall, A. Michel, D. Middlemiss, B. Ross, D. Scopes, M. Dowle (1992)
Pharmacological profile of GR117289 in vitro: a novel, potent and specific non‐peptide angiotensin AT1 receptor antagonistBritish Journal of Pharmacology, 107
-
P. Timmermans, P. Wong, A. Chiu, W. Herblin, P. Benfield, D. Carini, R. Lee, R. Wexler, J. Saye, R. Smith (1993)
Angiotensin II receptors and angiotensin II receptor antagonists.Pharmacological reviews, 45 2
-
P. Timmermans, D. Carini, A. Chiu, J. Duncia, W. Price, G. Wells, P. Wong, R. Wexler, A. Johnson (1990)
Nonpeptide angiotensin II receptor antagonists.Trends in pharmacological sciences, 12 2
- Publisher
- Springer Journals
- Copyright
- Copyright © 2000 by Plenum Publishing Corporation
- Subject
- Biomedicine; Pharmacology/Toxicology; Pharmacy; Biochemistry, general; Medical Law; Biomedical Engineering
- ISSN
- 0724-8741
- eISSN
- 1573-904X
- DOI
- 10.1023/A:1007600924033
- Publisher site
- See Article on Publisher Site
Abstract
Purpose. The aim of the present work is to describe the inhibitory properties of LY301875 and LY303336, two polysubstituted 4-aminoimidazole AT1 receptor antagonists, on CHO cells expressing human recombinant AT1 receptors.
Journal
Pharmaceutical Research – Springer Journals
Published: Oct 19, 2004